Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares. The report covers the month of June 2025, specifically detailing share repurchases executed on June 16, 2025. The Company is a Foreign Private Issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing details a specific share buyback transaction rather than general financial performance metrics such as revenue or profit.
- Shares Purchased (June 16, 2025): 453,531 ordinary shares.
- Price Range: Lowest price paid was 1,485.50 GBp; highest price paid was 1,506.00 GBp.
- Volume-Weighted Average Price (VWAP): 1,493.90 GBp.
- Trading Venue: London Stock Exchange (XLON).
- Broker: Merrill Lynch International.
- Treasury Shares Held: 221,398,892 ordinary shares following the transaction.
- Shares in Issue (excluding Treasury): 4,093,902,697 ordinary shares.
- Voting Rights in Treasury: 5.41% of total voting rights.
Material Changes
The filing indicates that the purchase on June 16, 2025, was part of an existing buyback programme executed under a non-discretionary agreement entered into on June 4, 2025. Since the commencement of this agreement on June 4, 2025, the Company has purchased an aggregate of 3,264,509 ordinary shares. The filing does not provide comparative data for prior periods regarding buyback volume or price.
Guidance, Outlook, and Risks
The filing confirms the continuation of the Company's existing share buyback programme. It states that purchased shares will be held as Treasury shares. No specific financial guidance, forward-looking statements regarding revenue or earnings, or discussion of material risks and contingencies is included in this specific transaction report.
Investor Verification Checklist
- Verify the total remaining authorization under the Company's existing buyback programme.
- Confirm the total number of shares purchased under the non-discretionary agreement since June 4, 2025 (stated as 3,264,509).
- Review the impact of the 5.41% treasury share holding on voting rights calculations for major shareholders.
- Check subsequent filings for updates on the completion or extension of the buyback programme.